Severe COVID-19 patients exhibit widespread complement activation which is characterized by C3 activation, C3a generation, C3 fragment deposition and increased serum C5a levels (Mastaglio et al., 2020; Noris et al., 2020; Risitano et al., 2020). Here, C3 is linked to COVID-19.